Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.17%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
59.12 0.00(0.00%) Jan 13, 4:00PM EST
Prev Close:59.12
Open:58.95
Bid:58.05 x 500
Ask:70.65 x 100
1y Target Est:58.93
Beta:2.28247
Earnings Date:Feb 7 - Feb 13 (Est.)
Day's Range:58.26 - 59.69
52wk Range:26.02 - 75.36
Volume:793,833
Avg Vol (3m):1,395,130
Market Cap:8.37B
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SGEN 0.00%8.37B
IMGN 0.00%212.14M
1 0.00%N/A
PFEDown 0.25%197.34B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.94
Quarterly EPS Est (Dec-16) :-0.33
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-3.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS (brentuximab vedotin), an antibody-drug conjugate for the treatment of relapsed Hodgkin lymp... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback